Gestational diabetes is traditionally treated with insulin. Metformin is a peroral drug used
worldwide in the treatment of type 2 diabetes and also in a few studies on patients with
gestational diabetes. The investigators aim is to compare insulin and metformin in the
treatment of gestational diabetes. The investigators hypothesis is that there is no
difference between insulin and metformin treated mothers in the main outcome criteria (birth
weight, neonatal complications).